TTP LabTech's Mirrorball offers equivalent data with minimal changes to assay protocols
Royston, UK - TTP LabTech has today released the results of a valuable benchmarking study using its Mirrorball® antibody discovery system. The data accurately demonstrates that Mirroball offers equivalent data to the discontinued ABI 8200 FMAT® instrument, with minimal changes to assay protocols.
Mix-and-read assays, first popularized as FMAT assays, were developed to overcome the problems associated with automating ELISAs particularly in cell-based methods. This new comparative study has used the FMAT assay to look at bead-based quantitation of a soluble protein (rabbit IgG) and antibody binding to EGF receptors expressed in A459 cells. The Mirrorball system scanned the entire well, and FMAT reported data from only a 1 mm2 area in each well. Beads were identified by laser scatter on Mirrorball and fluorescence on FMAT. The Mirrorball system could enumerate beads in all wells, in contrast to FMAT which could not detect all beads below 1 ng/mL rabbit IgG.
The study demonstrated that the performance of both systems was broadly similar. For the full application note detailing this comparative study please visit http://ttplabtech.com/emailers/mirrorball-benchmarking-study.html
For more information about Mirrorball, please visit ttplabtech.com/products/mirrorball/overview.html
About TTP LabTech Ltd
Based near Cambridge, UK, TTP LabTech supplies laboratory instrumentation for the healthcare, biotech and pharmaceutical sectors. TTP LabTech's products are designed to increase efficiency, effectiveness, flexibility or overall capability in key biopharmaceutical research processes including compound storage (comPOUND®), low volume liquid handling (mosquito®), fluorescence detection (Acumen®) and antibody discovery (Mirrorball®).
TTP LabTech Limited
+44 (0)1763 262626
Alto Marketing Limited
+44 (0)1489 55767